Perioperative complications in women undergoing thermal balloon endometrial ablation after one or more cesarean deliveries
European Journal of Obstetrics & Gynecology and Reproductive Biology · 2024
DOI: 10.1016/j.ejogrb.2024.05.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Obstetrics & Gynecology and Reproductive Biology, 2024. Verfasst von Simon-Hermann Enzelsberger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Obstetrics and Gynecological Endocrinology, Kepler University Hospital, Johannes Kepler University Linz, Altenberger Strass…. Hauptthemen laut MEDLINE: Endometrial Ablation Techniques, Cesarean Section, Postoperative Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVE: To determine whether thermal ballon endometrial ablation can be safely performed after one or more cesarean sections. STUDY DESIGN: Retrospective cohort study including all women who underwent thermal balloon endometrial ablation at the Kepler University Hospital, Austria, between November 2017 and December 2022. For the analysis of the study endpoints, the dataset was divided into two groups: women with at least one cesarean section, and women without a history of cesarean section. Complications were classified according to the Clavien-Dindo classification. Association was tested using Fisher's exact test. RESULTS: Of the 361 women included, 29.3 % (n = 105) had at least one previous cesarean section. The association between intraoperative uterine rupture and previous cesarean section was not statistically significant (0 % vs. 1 %; p = 0.292). Only one uterine rupture was observed in the cesarean section group, which was located at the uterine fundus after a preoperatively unknown previous uterine perforation during IUD insertion. Secondary endpoints (overall complication rate, postoperative endometritis, vesicouterine fistula, different grades of Clavien-Dindo-classification) showed no significant associations either, even when considering the number of previous cesarean sections. The readmission rate to the clinic for bleeding disorders was 11.4 % in both groups (p = 1.00). CONCLUSION: Women who have had one or more prior cesarean sections with transverse isthmocervical hysterotomy do not appear to have an increased risk of complications in a subsequent thermal balloon endometrial ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, Obstetrics and Gynecological Endocrinology, Kepler University Hospital, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz and Krankenhausstrasse 9, 4020 Linz, Austria. Electron…
- Department of Gynecology, Obstetrics and Gynecological Endocrinology, Kepler University Hospital, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz and Krankenhausstrasse 9, 4020 Linz, Austria.
Zitieren
APA
Enzelsberger, S. H., Oppelt, P., Enengl, S., Palme, I. S., & Trautner, P. S. (2024). Perioperative complications in women undergoing thermal balloon endometrial ablation after one or more cesarean deliveries. European Journal of Obstetrics & Gynecology and Reproductive Biology. https://doi.org/10.1016/j.ejogrb.2024.05.034
Vancouver
Enzelsberger SH, Oppelt P, Enengl S, Palme IS, Trautner PS. Perioperative complications in women undergoing thermal balloon endometrial ablation after one or more cesarean deliveries. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2024. doi:10.1016/j.ejogrb.2024.05.034
BibTeX
@article{Enzelsberger2024,
author = {Enzelsberger, Simon-Hermann and Oppelt, Peter and Enengl, Sabine and Palme, Isabella Sophie and Trautner, Philip Sebastian},
title = {Perioperative complications in women undergoing thermal balloon endometrial ablation after one or more cesarean deliveries},
journal = {European Journal of Obstetrics & Gynecology and Reproductive Biology},
year = {2024},
doi = {10.1016/j.ejogrb.2024.05.034}
}
EUVIMED